Red Tortoise LLC Alx Oncology Holdings Inc Transaction History

Red Tortoise LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$5.84 - $17.56 $1,985 - $5,970	-340 Closed	0 $0
Q3 2023 Nov 02, 2023	BUY	$4.19 - $7.35 $100 - $176	24 Added 7.59%	340 $1,000
Q2 2023 Jul 26, 2023	BUY	$4.37 - $9.56 $1,380 - $3,020	316 New	316 $2,000
Q4 2022 Feb 01, 2023	BUY	$9.51 - $12.95 $1,863 - $2,538	196 New	196 $2,000
Q3 2021 Nov 07, 2022	BUY	$52.51 - $80.91 $10,291 - $15,858	196 New	196 $2,000

31.6M

53.8K

11.7K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $83.1M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Red Tortoise LLC, based on Form 13F filings with the SEC.

Stay updated on Red Tortoise LLC with notifications on news.